News

Fierce Pharma5d

10 years of Tagrisso: AstraZeneca unveils first TV ad for lung cancer treatment

Ahead of the 10-year anniversary of Tagrisso’s initial FDA approval this fall, AstraZeneca has debuted the first ...

AstraZeneca's Multi-Billion Dollar Cancer Drug Tagrisso Improves Overall Survival In Patients With Advanced Lung Cancer

AstraZeneca Plc (NASDAQ:AZN) released high-level results from the final overall survival (OS) analysis of the FLAURA2 Phase 3 ...
PMLive8d

AstraZeneca shares late-stage results for Tagrisso combination in lung cancer

AstraZeneca (AZ) has shared positive overall survival (OS) results from a late-stage study of its epidermal growth factor ...

AstraZeneca announces $50 billion US manufacturing investment, matching its big pharma peers

AstraZeneca ( AZN) said it is investing $50 billion in U.S. manufacturing by 2030, following the lead of big pharma peers ...

AstraZeneca (LSE:AZN) TAGRISSO Shows Clinically Meaningful Survival Improvement In Lung Cancer Study

AstraZeneca (LSE:AZN) recently announced positive developments regarding TAGRISSO®'s survival benefits in treating non-small ...
Pharmabiz7d

AstraZeneca announces positive results from FLAURA2 phase III trial of Tagrisso plus chemotherapy to treat EGFR-mutated advanced lung cancer

AstraZeneca announces positive results from FLAURA2 phase III trial of Tagrisso plus chemotherapy to treat EGFR-mutated advanced lung cancer: Cambridge, UK Tuesday, July 22, 2025, ...
Fierce Pharma7d

AstraZeneca, facing lung cancer challenge from J&J, touts life-extension benefit for Tagrisso combo

AstraZeneca is raising its defenses against Johnson & Johnson in a fierce competition in EGFR-mutated non-small cell lung cancer. | Following an FDA approval last year based on a tumor progression ...
Nasdaq10mon

AstraZeneca: FDA Approves Tagrisso To Treat Unresectable Stage ... - Nasdaq

Dave Fredrickson, Executive Vice President, Oncology Business Unit, AstraZeneca, said, "The approval of Tagrisso for patients with Stage III, unresectable EGFR-mutated non-small cell lung cancer ...